Welcome!

News Feed Item

Orthopaedics: Market Prospects & Global Competition

NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orthopaedics: Market Prospects & Global Competition

http://www.reportlinker.com/p01054660/Orthopaedics-Market-Prospects--Global-Competition .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Growth in the global orthopaedic market is projected to be 8% over the period 2012-17. By 2017, orthopaedic revenues are expected to total US$51.1 billion compared with US$34.7 billion in 2012 - but which companies are driving this growth?

The orthopaedic market has not been immune to the economic downturn that has plagued world economies in recent times. Some of the smaller companies, particularly those at the cutting edge of the market, found themselves short of cash and with little in the way of white knights to help make up the shortfall.

Now things are slowly changing. Private equity has returned to the industry and some of those calls for cash are finally getting answered by investors. It has become noticeable that a number of these investors have been able to successfully sell some of their business holdings with their pride relatively intact. And the reasons why we need these devices are growing ever more present.

The strength of the orthopaedics sector is that the fundamentals remain strong. It is one of the fastest growing sectors in the industry, thanks to the impact of an expanding elderly population and the associated steady rise and diagnosis in musculoskeletal disorders.

Use this new report to easily answer key business questions such as:

What developments will underpin the 2012-17 CAGR of 8.2% in the artificial joint sector?

What new products and services has Integra LifeSciences introduced in 2012?

What is the product and service line of the newly merged DePuy Synthes?

What are the latest developments in worldwide regulation and how are they affecting the orthopaedic sector?

Does ConforMIS patented i-fit technology signal progression on the development of bespoke, patient specific implants?

Which company posted flat sales in the US but grew revenues in Europe and Asia by 10% and 16% respectively in 2011?

Who is active in the foot and ankle ortho sector and what are their competing products?

A complete analysis packed with facts, forecasts and

detailed company evaluations

Regulation: First Approval – why some companies prefer Europe over the USA

There is increasing concern from manufacturers that access to the world's largest orthopaedic market is being frustrated by the FDA's lengthy and costly approval process. Some companies have made conscious efforts to avoid the US market, citing the expense and uncertainty of the FDA process as the reasons. Indeed, it is often seen as a preferred option for US start-ups to find their feet - and their revenues - in the European market. Faced without the possibility of much needed revenue, a massive regulatory bill and a nervy team of investors, companies eyeing the US market are required to sit tight as the FDA goes through its safety and efficacy review processes.

Study shows the contrasts

The contrast in regulatory approaches in Europe could not be clearer. According to a 2010 Stanford University study in the US, entitled "FDA Impact on US Medical Technology Innovation, for a PMAtype product, the time span from the initial contact with the regulatory authority until market launch amounted to 54 months in the US, compared with 11 months in Europe. On average, a market launch in Europe can be realised three years earlier, with significantly lower costs. Financially, it can take a device manufacturer three to five years to get a medical device approved in Japan and China, at a cost of US$3 million or less in each market. In Europe, the time can range from six months to two years and cost around US$2 million. In contrast, getting approval in the US for a medical device can take between two and seven years and cost between US$50 to US$100 million. Time frames differ for those pursuing the 510(k) route to approval, but even here the FDA's anxieties can be seen in requests for further information after first review: 3 out of 4 applications will now be referred back to the company. The trend, illustrated in the chart below, shows that this is long established.

CONTENTS

INTRODUCTION..1

AN OVERVIEW OF REGULATORY ISSUES IN THE US, EUROPE AND BEYOND ..3

ORTHOPAEDIC COMPANIES FIVE-YEAR SALES REVIEW.23

AAP IMPLANTATE25

KEY PERSONNEL..25

COMPANY OVERVIEW .25

KEY MILESTONES 25

AGREEMENTS.26

TECHNOLOGIES/PRODUCTS27

KEY FINANCIAL DATA30

ALPHATEC SPINE.31

KEY PERSONNEL..31

COMPANY OVERVIEW .31

KEY COMPETITORS 31

KEY MILESTONES 31

AGREEMENTS.32

TECHNOLOGIES/PRODUCTS34

KEY FINANCIAL DATA41

AMEDICA..43

KEY PERSONNEL..43

COMPANY OVERVIEW .43

KEY MILESTONES 43

AGREEMENTS 44

TECHNOLOGIES/PRODUCTS45

KEY FINANCIAL DATA47

ANIKA THERAPEUTICS 49

KEY PERSONNEL..49

COMPANY OVERVIEW .49

KEY COMPETITORS 49

KEY MILESTONES 49

AGREEMENTS.50

R&D MILESTONES ..50

TECHNOLOGIES/PRODUCTS50

KEY FINANCIAL DATA51

ARTHROCARE 53

KEY PERSONNEL..53

COMPANY OVERVIEW .53

KEY COMPETITORS 53

KEY MILESTONES 53

AGREEMENTS.54

R&D MILESTONES ..54

TECHNOLOGIES/PRODUCTS55

KEY FINANCIAL DATA63

ARTIMPLANT 65

KEY PERSONNEL. 65

COMPANY OVERVIEW 65

KEY MILESTONES .. 65

AGREEMENTS 65

R&D MILESTONES .66

TECHNOLOGIES/PRODUCTS.. 67

KEY FINANCIAL DATA.. 67

BACTERIN INTERNATIONAL 69

KEY PERSONNEL. 69

COMPANY OVERVIEW 69

KEY COMPETITORS .. 69

KEY MILESTONES .. 69

AGREEMENTS 70

R&D MILESTONES . 70

TECHNOLOGIES/PRODUCTS.. 71

KEY FINANCIAL DATA.. 71

BIOMET. 73

KEY PERSONNEL. 73

COMPANY OVERVIEW 73

KEY COMPETITORS .. 73

KEY MILESTONES .. 74

AGREEMENTS 74

R&D MILESTONES . 75

TECHNOLOGIES/PRODUCTS.. 76

SUBSIDIARIES 81

KEY FINANCIAL DATA..88

BIOMIMETIC THERAPEUTICS. 89

KEY PERSONNEL.89

COMPANY OVERVIEW 89

KEY COMPETITORS ..89

KEY MILESTONES ..89

AGREEMENTS 91

R&D MILESTONES . 91

TECHNOLOGIES/PRODUCTS.. 93

KEY FINANCIAL DATA..94

BONESUPPORT 95

KEY PERSONNEL. 95

COMPANY OVERVIEW 95

KEY COMPETITORS .. 95

KEY MILESTONES .. 95

AGREEMENTS 95

TECHNOLOGIES/PRODUCTS..96

KEY FINANCIAL DATA.. 97

CAYENNE MEDICAL.. 99

KEY PERSONNEL.99

COMPANY OVERVIEW 99

KEY MILESTONES ..99

AGREEMENTS99

R&D MILESTONES ..100

PRODUCTS ..100

KEY FINANCIAL DATA 101SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE V

ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS

CO.DON . 103

KEY PERSONNEL..103

COMPANY OVERVIEW .103

KEY COMPETITORS 103

AGREEMENTS.103

R&D MILESTONES ..104

TECHNOLOGIES/PRODUCTS104

KEY FINANCIAL DATA104

CONFORMIS 105

KEY PERSONNEL..105

COMPANY OVERVIEW .105

KEY MILESTONES 105

AGREEMENTS.106

TECHNOLOGIES/PRODUCTS106

KEY FINANCIAL DATA106

CORIN..107

KEY PERSONNEL..107

COMPANY OVERVIEW .107

KEY MILESTONES 107

AGREEMENTS.107

R&D MILESTONES ..108

TECHNOLOGIES/PRODUCTS108

KEY FINANCIAL DATA.111

DEPUY SYNTHES ..113

KEY PERSONNEL113

COMPANY OVERVIEW ..113

KEY COMPETITORS .114

KEY MILESTONES .115

AGREEMENTS..116

TECHNOLOGIES/PRODUCTS.117

KEY FINANCIAL DATA134

DJO GLOBAL 135

KEY PERSONNEL.. 135

COMPANY OVERVIEW . 135

KEY COMPETITORS 135

KEY MILESTONES 135

AGREEMENTS 136

R&D MILESTONES .. 137

TECHNOLOGIES/PRODUCTS 137

KEY FINANCIAL DATA 147

EXACTECH.149

KEY PERSONNEL..149

COMPANY OVERVIEW .149

KEY COMPETITORS 149

KEY MILESTONES 149

AGREEMENTS.150

R&D MILESTONES .. 151

TECHNOLOGIES/PRODUCTS 151

KEY FINANCIAL DATA 157

GLOBUS MEDICAL159

KEY PERSONNEL.. 159

COMPANY OVERVIEW . 159

KEY COMPETITORS 159

KEY MILESTONES 159

R&D MILESTONES ..160

TECHNOLOGIES/PRODUCTS 161

KEY FINANCIAL DATA165

HANGER .167

KEY PERSONNEL.. 167

COMPANY OVERVIEW . 167

KEY COMPETITORS 167

KEY MILESTONES 167

AGREEMENTS.168

R&D MILESTONES ..168

TECHNOLOGIES/PRODUCTS169

KEY FINANCIAL DATA 171

INION173

KEY PERSONNEL.. 173

COMPANY OVERVIEW . 173

KEY MILESTONES 173

AGREEMENTS. 173

R&D MILESTONES 174

TECHNOLOGIES/PRODUCTS.174

KEY FINANCIAL DATA 176

INTEGRA LIFESCIENCES177

KEY PERSONNEL.. 177

COMPANY OVERVIEW . 177

KEY COMPETITORS 177

KEY MILESTONES 177

AGREEMENTS. 181

TECHNOLOGIES/PRODUCTS 181

KEY FINANCIAL DATA 191

K2M193

KEY PERSONNEL.. 193

COMPANY OVERVIEW . 193

KEY MILESTONES 193

AGREEMENTS.195

TECHNOLOGIES/PRODUCTS195

KEY FINANCIAL DATA 197

KANGHUI MEDICAL .. 199

KEY PERSONNEL..199

COMPANY OVERVIEW .199

KEY COMPETITORS 199

KEY MILESTONES 199

AGREEMENTS.200

TECHNOLOGIES /PRODUCTS..200

KEY FINANCIAL DATA202SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE VII

ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS

KFX MEDICAL. 203

KEY PERSONNEL..203

COMPANY OVERVIEW .203

KEY COMPETITORS 203

KEY MILESTONES 203

TECHNOLOGIES/PRODUCTS204

KEY FINANCIAL DATA204

KUROS BIOSURGERY 205

KEY PERSONNEL..205

COMPANY OVERVIEW .205

KEY MILESTONES 205

AGREEMENTS.205

R&D MILESTONES ..206

TECHNOLOGIES/PRODUCTS207

KEY FINANCIAL DATA208

LANX 209

KEY PERSONNEL..209

COMPANY OVERVIEW .209

KEY MILESTONES 209

AGREEMENTS.209

R&D MILESTONES .. 210

TECHNOLOGIES/PRODUCTS 210

KEY FINANCIAL DATA.211

LDR SPINE .213

KEY PERSONNEL.. 213

COMPANY OVERVIEW . 213

KEY COMPETITORS 213

KEY MILESTONES 213

R&D MILESTONES .. 214

TECHNOLOGIES/PRODUCTS 215

KEY FINANCIAL DATA 217

LIFE SPINE.219

KEY PERSONNEL.. 219

COMPANY OVERVIEW . 219

KEY MILESTONES 219

AGREEMENTS.220

TECHNOLOGIES/PRODUCTS220

KEY FINANCIAL DATA222

MAKO SURGICAL. 223

KEY PERSONNEL..223

COMPANY OVERVIEW .223

KEY COMPETITORS 223

KEY MILESTONES 223

AGREEMENTS.224

R&D MILESTONES ..224

TECHNOLOGIES/PRODUCTS224

KEY FINANCIAL DATA226VIII

TABLE OF CONTENTS ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION

MAZOR ROBOTICS . 227

KEY PERSONNEL..227

COMPANY OVERVIEW .227

KEY MILESTONES 227

AGREEMENTS.228

R&D MILESTONES ..228

TECHNOLOGIES/PRODUCTS229

KEY FINANCIAL DATA230

MEDICREA INTERNATIONAL 231

KEY PERSONNEL..231

COMPANY OVERVIEW .231

KEY MILESTONES 231

AGREEMENTS.231

R&D MILESTONES ..232

TECHNOLOGIES/PRODUCTS232

KEY FINANCIAL DATA233

MEDTRONIC 235

KEY PERSONNEL..235

COMPANY OVERVIEW .235

KEY COMPETITORS 235

KEY MILESTONES 236

AGREEMENTS.238

R&D MILESTONES ..239

TECHNOLOGIES/PRODUCTS240

KEY FINANCIAL DATA248

NUVASIVE 249

KEY PERSONNEL..249

COMPANY OVERVIEW .249

KEY COMPETITORS 249

KEY MILESTONES 250

AGREEMENTS.251

R&D MILESTONES ..251

TECHNOLOGIES/PRODUCTS252

KEY FINANCIAL DATA254

ORTHOFIX INTERNATIONAL. 255

KEY PERSONNEL..255

COMPANY OVERVIEW .255

KEY COMPETITORS 255

KEY MILESTONES 256

AGREEMENTS.257

TECHNOLOGIES/PRODUCTS258

KEY FINANCIAL DATA264

PIONEER SURGICAL TECHNOLOGY. 265

KEY PERSONNEL..265

COMPANY OVERVIEW .265

KEY MILESTONES 265

AGREEMENTS.266

R&D MILESTONES ..267

TECHNOLOGIES/PRODUCTS267

KEY FINANCIAL DATA270SEPTEMBER

RTI BIOLOGICS.. 271

KEY PERSONNEL..271

COMPANY OVERVIEW .271

KEY MILESTONES 271

AGREEMENTS.272

R&D MILESTONES ..272

TECHNOLOGIES/PRODUCTS273

KEY FINANCIAL DATA276

SI-BONE. 277

KEY PERSONNEL..277

COMPANY OVERVIEW .277

KEY COMPETITORS 277

KEY MILESTONES 277

R&D MILESTONES ..278

TECHNOLOGIES/PRODUCTS278

KEY FINANCIAL DATA278

SMALL BONE INNOVATIONS 279

KEY PERSONNEL..279

COMPANY OVERVIEW .279

KEY COMPETITORS 279

KEY MILESTONES 279

AGREEMENTS.280

R&D MILESTONES ..281

TECHNOLOGIES/PRODUCTS281

KEY FINANCIAL DATA284

SMITH & NEPHEW .. 285

KEY PERSONNEL..285

COMPANY OVERVIEW .285

KEY COMPETITORS 285

KEY MILESTONES 286

AGREEMENTS 287

R&D MILESTONES ..288

TECHNOLOGIES/PRODUCTS289

KEY FINANCIAL DATA292

SPINAL ELEMENTS . 295

KEY PERSONNEL..295

COMPANY OVERVIEW .295

KEY COMPETITORS 295

KEY MILESTONES 295

AGREEMENTS 295

R&D MILESTONES ..296

TECHNOLOGIES/PRODUCTS296

KEY FINANCIAL DATA297

SPINALMOTION 299

KEY PERSONNEL..299

COMPANY OVERVIEW .299

KEY MILESTONES 299

R&D MILESTONES ..299

TECHNOLOGIES/PRODUCTS300

KEY FINANCIAL DATA300X

SPINESMITH 301

KEY PERSONNEL..301

COMPANY OVERVIEW .301

KEY MILESTONES 301

AGREEMENTS.301

R&D MILESTONES ..302

TECHNOLOGIES/PRODUCTS302

KEY FINANCIAL DATA303

STANMORE IMPLANTS 305

KEY PERSONNEL..305

COMPANY OVERVIEW .305

KEY MILESTONES 305

AGREEMENTS.305

TECHNOLOGIES/PRODUCTS306

KEY FINANCIAL DATA308

STRYKER 309

KEY PERSONNEL..309

COMPANY OVERVIEW .309

KEY COMPETITORS 309

KEY MILESTONES 310

AGREEMENTS..311

R&D MILESTONES 311

TECHNOLOGIES/PRODUCTS 312

KEY FINANCIAL DATA320

SYMMETRY MEDICAL 321

KEY PERSONNEL.. 321

COMPANY OVERVIEW . 321

KEY COMPETITORS 321

KEY MILESTONES ..321

AGREEMENTS 322

TECHNOLOGIES/PRODUCTS323

KEY FINANCIAL DATA325

TORNIER 327

KEY PERSONNEL..327

COMPANY OVERVIEW .327

KEY MILESTONES 327

AGREEMENTS.328

R&D MILESTONES ..328

TECHNOLOGIES/PRODUCTS329

KEY FINANCIAL DATA333

TRANS1.. 335

KEY PERSONNEL..335

COMPANY OVERVIEW .335

KEY COMPETITORS 335

KEY MILESTONES 335

AGREEMENTS.336

TECHNOLOGIES/PRODUCTS336

KEY FINANCIAL DATA337

WRIGHT MEDICAL GROUP 339

KEY PERSONNEL..339

COMPANY OVERVIEW .339

KEY COMPETITORS 339

KEY MILESTONES 339

AGREEMENTS.341

R&D MILESTONES ..341

TECHNOLOGIES/PRODUCTS342

KEY FINANCIAL DATA349

X-SPINE SYSTEMS.351

KEY PERSONNEL..351

COMPANY OVERVIEW .351

KEY MILESTONES 351

AGREEMENTS.351

TECHNOLOGIES/PRODUCTS352

KEY FINANCIAL DATA353

ZIMMER. 355

KEY PERSONNEL..355

COMPANY OVERVIEW .355

KEY COMPETITORS355

KEY MILESTONES 355

AGREEMENTS.357

R&D MILESTONES ..358

TECHNOLOGIES/PRODUCTS359

KEY FINANCIAL DATA368

To order this report:

Orthopedic Industry: Orthopaedics: Market Prospects & Global Competition

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Niagara Networks exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
When you focus on a journey from up-close, you look at your own technical and cultural history and how you changed it for the benefit of the customer. This was our starting point: too many integration issues, 13 SWP days and very long cycles. It was evident that in this fast-paced industry we could no longer afford this reality. We needed something that would take us beyond reducing the development lifecycles, CI and Agile methodologies. We made a fundamental difference, even changed our culture...